ANIP

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is a biopharmaceutical company founded in 2001 and headquartered in Baudette, Minnesota. The company has evolved from a traditional generic drug manufacturer into a specialized pharmaceutical company with a growing focus on rare disease treatments. ANI went public in 2000 and has undergone significant transformation over the past few years, particularly through strategic acquisitions and the successful launch of its rare disease franchise centered around Cortrophin Gel. Today, the company operates as a diversified pharmaceutical manufacturer serving both the generic and specialty drug markets across the United States and Canada.